Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Minimally Invasive Surgery of the Hip Versus Standard Approach

This study has been completed.
Sponsor:
Collaborator:
Zimmer Biomet
Information provided by (Responsible Party):
Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00261040
First received: November 30, 2005
Last updated: October 24, 2011
Last verified: October 2011
  Purpose
The purpose of this study is to determine if there is a difference in terms of length of hospital stay and post-operative outcomes between patients whose total hip replacement surgery is performed with a minimally invasive versus standard surgical approach.

Condition Intervention
Hip Arthroplasty
Osteoarthritis
Procedure: minimally invasive total hip arthroplasty
Procedure: Standard

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Participant)
Official Title: Minimally Invasive Surgery of the Hip: A Randomized Study

Further study details as provided by Ottawa Hospital Research Institute:

Primary Outcome Measures:
  • Length of Stay [ Time Frame: Post-op ]

Secondary Outcome Measures:
  • WOMAC SF-36 Harris Hip Get up and Go Operative Details Post-operative Complications [ Time Frame: Pre-op, 6, 12, 24 months post-op ]

Estimated Enrollment: 40
Study Start Date: June 2003
Study Completion Date: May 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: MIS
Minimally invasive hip surgery
Procedure: minimally invasive total hip arthroplasty
minimally invasive total hip arthroplasty
Other Name: non applicable
Active Comparator: Standard
Standard approach to hip surgery
Procedure: Standard
standard approach hip surgery
Other Name: non applicable

Detailed Description:
Traditional techniques for total hip arthroplasty (THA) require complete visualization of the acetabulum and proximal femur since anatomic landmarks are crucial for correct orientation of the prosthetic components. All surgeons are taught that a wide surgical exposure is one of the most important factors in performing successful THA. Traditionally, it was impossible to achieve accurate fixation and orientation of the components without complete visualization of bony landmarks. These extensile exposures facilitate accurate implant alignment, but at the expense of more extensive soft tissue dissection. Little clinical research has been undertaken to relate the surgical approach to postoperative complications or patient function. Furthermore, despite the good overall results of THA, the recovery time to improved function can be lengthy. Blood loss is expected to be directly related to the extent of the surgical exposure and to influence patients outcomes. Based upon these facts, an important principle of arthroplasty surgery is to minimize the amount of soft tissue trauma while being able to achieve the surgical goal of reconstructing the arthritic hip joint. By definition, minimally invasive surgical (MIS) procedures result in less soft tissue disruption, which in turn should reduce pain, expedite healing, decrease recovery time, and potentially reduce the number of associated complications.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

BMI > 30 kg/m2 No prior ipsilateral hip surgery Osteoarthritis

Exclusion Criteria:

Patients with grossly distorted bony anatomy whereby standard implants are contraindicated; i.e. congenital dysplasia of the hip, proximal femoral abnormalities, etc

Rheumatoid Arthritis

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00261040

Sponsors and Collaborators
Ottawa Hospital Research Institute
Zimmer Biomet
Investigators
Principal Investigator: Paul Kim, MD OHRI
  More Information

Responsible Party: Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier: NCT00261040     History of Changes
Other Study ID Numbers: OHREB 2003211-01H
Study First Received: November 30, 2005
Last Updated: October 24, 2011

Keywords provided by Ottawa Hospital Research Institute:
Osteoarthritis
Total Hip Arthroplasty
Minimally Invasive Surgery

Additional relevant MeSH terms:
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on May 24, 2017